Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Targeting a subtype of GABA-A receptors to treat perioperative neurocognitive disorders

EF 2018-19

Résumé
Millions of surgeries occur around the world each year where patients are exposed to general anesthetics. A proportion of these patients will experience deficits in learning and memory after their operation that can persist for months to years. These cognitive deficits have significant effects on a person’s life as they are associated with early retirement and increased mortality. There is a need to develop effective treatments as the current therapeutic tools are inadequate. Although the causes of these deficits are multifactorial, research has illustrated that general anesthetics are a key player. It has been determined that these cognitive deficits are triggered by an anesthetic-induced increase in a specific receptor function in the brain. Upregulation of this receptor can lead to the disruption of learning and memory. However, the exact mechanisms underlying the upregulation of this receptor remain unknown. The identification of this receptor was crucial for the development of pharmacological interventions. Therapeutic drugs are now being developed to selectively block the function of this receptor, thus preventing deficits. However, these drugs are limited by the strength of their effects and their selectivity. Therefore, it would be beneficial to develop alternative therapeutic strategies to attenuate the receptor function. To do so, the mechanism driving the increase of this receptor must be investigated. As a result, the goals of my project will be to 1) screen for the best available drug and 2) to investigate the mechanisms driving the upregulation of this receptor, in order to identify novel therapeutic targets.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
406334
Name
Manzo Marc Anthony
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Targeting a subtype of GABA-A receptors to treat perioperative neurocognitive disorders
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anesthesia; Cognitive Deficits; Extrasynaptic; Gaba-A Receptor; Learning And Memory; Perioperative; Tonic Inhibition; Translational Research
Abstract
Millions of surgeries occur around the world each year where patients are exposed to general anesthetics. A proportion of these patients will experience deficits in learning and memory after their operation that can persist for months to years. These cognitive deficits have significant effects on a person’s life as they are associated with early retirement and increased mortality. There is a need to develop effective treatments as the current therapeutic tools are inadequate. Although the causes of these deficits are multifactorial, research has illustrated that general anesthetics are a key player. It has been determined that these cognitive deficits are triggered by an anesthetic-induced increase in a specific receptor function in the brain. Upregulation of this receptor can lead to the disruption of learning and memory. However, the exact mechanisms underlying the upregulation of this receptor remain unknown. The identification of this receptor was crucial for the development of pharmacological interventions. Therapeutic drugs are now being developed to selectively block the function of this receptor, thus preventing deficits. However, these drugs are limited by the strength of their effects and their selectivity. Therefore, it would be beneficial to develop alternative therapeutic strategies to attenuate the receptor function. To do so, the mechanism driving the increase of this receptor must be investigated. As a result, the goals of my project will be to 1) screen for the best available drug and 2) to investigate the mechanisms driving the upregulation of this receptor, in order to identify novel therapeutic targets.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Manzo, Marc Anthony
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~